Shimadzu, one of the world leaders in analytical instrumentation, is inviting young scientists from all over Europe for to apply for laboratory bench space for their own research work as part of the lab4you student program.

In the “Shimadzu Laboratory World” at the European headquarters in Duisburg, Germany, they have the opportunity to pursue their creative research approaches and use state-of-the-art laboratory equipment to produce results. The latest analytical equipment from HPLC/UHPLC, SFC and GC as well as mass spectrometry, MALDI, spectroscopy (UV, IR, FTIR, ICP) and materials testing technology are available on 1,500 square meters, ensuring the best analytical results.

The lab4you program is affiliated with the Shimadzu European Innovation Center. It brings together business and academia and works with universities across Europe to develop new analytics solutions for tomorrow, that is, new methods, instruments, techniques and software solutions.

Apply here

Interested scientists can apply by October 31, 2021 at www.shimadzu.eu/lab4you with a short abstract of their research work in English. Laboratory space will be available for the duration of the research project. Requirements for participation in the lab4you program are a degree in the natural sciences, an inspiring research topic and prior knowledge of analytical technology. The program is aimed at master’s and doctoral students as well as post-docs from all scientific fields in which analytical instrumentation or materials testing technology play a role. An internal jury will select the successful applicant.

In a new study, researchers used exosomes to deliver novel protein into the cells of mice infected with HIV. The protein attached to HIVs’ genetic material and prevented itfrom replicating, resulting in reduced levels of HIV in the bone marrow, spleen, and brain. The study, funded by the US NIH’s National Institute of Mental Health […]

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vulputate condimentum eros. Sed quis luctus leo. Pellentesque pellentesque magna justo, vel ornare purus convallis id. Nunc a libero in sem vehicula pulvinar gravida mattis sem.

An estimated 14−17% of hospitalized COVID-19 patients develop a severe form of the disease, requiring oxygen support and admission to the intensive care unit.Underlying medical conditions such as diabetes, chronic cardiac diseases, chronic kidney diseases, obesity, and some genetic predispositions contribute to the severity of COVID-19.

As a result of strong business growth over the last few years – sample management specialists – Ziath has made a new strategic investment to further support its expanding international operations.